AI in Healthcare July 8, 2024
Oncologists using or considering AI tools tend to agree among themselves on three points of ethics. One, AI models must be explainable by oncologists. Two, patients must consent to the use of AI in their treatment decisions. And three, it’s up to oncologists to safeguard patients against AI biases.
The findings are from a survey project conducted at Harvard Medical School and published this spring in JAMA Network Open.
Andrew Hantel, MD, and collegues report that 204 randomly selected oncologists from 37 states completed questionnaires. Among the team’s key findings:
- If faced with an AI treatment recommendation that differed from their own opinion, more than a third of the field, 37%, would let the patient decide which of the...